Home News Company news...
July 15, 2024

MEBO International Shines at Monash Wound Conference: Leading Innovation and Collaboration

From July 13-14, 2024, the Monash International Wound Conference at Monash University in Malaysia attracted top scholars and industry leaders from Asia, Oceania, and Europe. MEBO International, a key partner and core exhibitor, presented its cutting-edge wound management and regenerative medical technology advancements.

 

Collaboration with Monash University

MEBO International collaborated with Monash University to explore the latest research and practices in wound management. The conference, themed "Opportunities and Challenges: Reshaping Wound Care Services," encouraged interdisciplinary exchanges and inspired innovative strategies to address global health challenges, such as chronic wounds in older people.

 

Highlighting MEBO's Star Products

MEBO International showcased its flagship products, including Moist Exposed Burn Ointment (MEBO) and a range of skin repair solutions. Known for their unique efficacy and safety, these products have earned high praise in Malaysia and globally. High-ranking officials from Malaysia's Ministry of Health, top scholars, and industry leaders visited MEBO's booth, commending the company's innovation and contributions.

 

Active Participation and Acclaim

The MEBO International delegation engaged in various academic activities, fostering in-depth exchanges with attendees. Esteemed physicians recommended MEBO for chronic wound treatment, highlighting its superior clinical results. Dr. Lee Chin Yen from Ampang Hospital in Malaysia delivered a standout presentation on "Innovative Applications of MEBO in Stage 4 Pressure Ulcer Management," showcasing MEBO's leading position in the field.

 

Commitment to Future Innovation

MEBO International remains dedicated to innovation, increasing investment in R&D, and promoting global medical cooperation. By partnering with Monash University and other international entities, MEBO aims to elevate global wound management standards and contribute significantly to the field's advancement.

 


 

About MEBO

Founded in 1987 by Professor Rongxiang Xu, a distinguished Chinese life scientist, MEBO Group is a multinational headquartered in both China and the USA. It integrates research, development, and sales across the pharmaceuticals, medical devices, health foods, and cosmetics sectors.

At its core, MEBO focuses on regenerative life sciences, innovating with over 100 patents and more than ten joint research bases to enhance and enable the body's own regenerative abilities.

As a leader in regenerative life science, MEBO's extensive research facilities and products impact over 100 countries globally, pioneering new frontiers in the regenerative life world.